Scienza Health today announced a major expansion of its partnership with Samsung Electronics America, bringing its ERaaS (Exam Room as a Service) cognitive and neurological screening capabilities to Samsung's Galaxy ecosystem. The FDA-registered DigitalHumanOS™ platform will now be accessible on Galaxy smartwatches, smartphones, tablets, and Samsung TVs, enabling healthcare providers to deliver multimodal assessments across any Samsung device—all through a web-based platform requiring no consumer downloads or subscriptions.
This expansion transforms how healthcare providers deliver cognitive and neurological screening, making evidence-based assessments available wherever patients are—at home, in clinical settings, or through telehealth. The web-based ERaaS platform maintains its B2B focus, serving healthcare organizations while leveraging the ubiquity of Samsung's Galaxy ecosystem. ... The October 2025 pilot programs will launch with skilled nursing facilities deploying Galaxy devices for cognitive monitoring, remote patient check-ins, and family communication—all integrated with existing clinical workflows through the ERaaS platform.
Key Platform Capabilities Across Galaxy Ecosystem
ERaaS on Samsung Galaxy devices delivers:
- Web-based delivery requiring no consumer downloads, app stores, or subscription management
- Samsung DeX functionality enabling seamless transitions from mobile to desktop workstation modes
- Multimodal screening across Galaxy watches (activity monitoring), phones (telehealth), tablets (consultations), and TVs (home care)
- Voice-enabled AI orchestrating nine specialized Digital Humans for comprehensive assessment
- 94% diagnostic accuracy for cognitive, depression, and neurological screening maintained across all device types
"Our expanded Samsung partnership democratizes access to sophisticated cognitive screening. Healthcare providers can now deliver FDA-registered assessments through devices patients already own—Galaxy watches, phones, tablets, even their TVs—all without requiring patients to download apps or manage subscriptions."
— David Kaiser, CEO of Scienza Health
Availability and Rollout
The Galaxy ecosystem expansion launches with strategic deployment:
- October 2025 Pilot Programs: Skilled nursing facilities deploying Galaxy devices for cognitive monitoring and family communication
- Samsung DeX Integration: Complete workstation functionality across Galaxy tablets and phones
- Home Care Enablement: Samsung TV integration for in-home cognitive screening and telehealth
- Existing ERaaS Customers: Automatic access to Galaxy ecosystem capabilities through web-based platform
Healthcare organizations interested in Galaxy ecosystem deployment can request ROI analyses at www.scienzahealth.com/eraas. The web-based ERaaS platform requires no IT integration, deploys in 30 minutes, and includes Samsung hardware, DigitalHumanOS™ software, training, and support with 60-day ROI guarantee.
Important Notes on Privacy, Security, and Regulatory Status: Scienza's AI models are trained on 11 million de-identified patient records spanning 15 years from major health systems. All data handling complies with HIPAA privacy and security requirements. The company's HITRUST certification and SOC 2 Type II compliance ensure enterprise-grade security across all Galaxy device integrations. FDA registration applies to DigitalHumanOS™ software and workflow automation—not to Samsung Galaxy hardware, which remains consumer electronics. Healthcare providers maintain full control over patient data and clinical decision-making. ERaaS operates as a B2B platform serving healthcare organizations; no direct-to-consumer services or patient subscriptions are offered through Galaxy devices.